AEG 3482

inhibitor of Jun kinase (JNK)-dependent apoptosis CAS# 63735-71-7

AEG 3482

Catalog No. BCC8088----Order now to get a substantial discount!

Product Name & Size Price Stock
AEG 3482: 5mg $69 In Stock
AEG 3482: 10mg Please Inquire In Stock
AEG 3482: 20mg Please Inquire Please Inquire
AEG 3482: 50mg Please Inquire Please Inquire
AEG 3482: 100mg Please Inquire Please Inquire
AEG 3482: 200mg Please Inquire Please Inquire
AEG 3482: 500mg Please Inquire Please Inquire
AEG 3482: 1000mg Please Inquire Please Inquire
Related Products
  • AG-18

    Catalog No.:BCC1051
    CAS No.:118409-57-7
  • AP26113

    Catalog No.:BCC1069
    CAS No.:1197958-12-5
  • WZ4002

    Catalog No.:BCC1074
    CAS No.:1213269-23-8
  • WZ8040

    Catalog No.:BCC1075
    CAS No.:1214265-57-2

Quality Control of AEG 3482

Number of papers citing our products

Chemical structure

AEG 3482

3D structure

Chemical Properties of AEG 3482

Cas No. 63735-71-7 SDF Download SDF
PubChem ID 698112 Appearance Powder
Formula C10H8N4O2S2 M.Wt 280.33
Type of Compound N/A Storage Desiccate at -20°C
Synonyms AEG-3482,AEG3482
Solubility Soluble to 100 mM in DMSO and to 5 mM in ethanol
Chemical Name 6-phenylimidazo[2,1-b][1,3,4]thiadiazole-2-sulfonamide
SMILES C1=CC=C(C=C1)C2=CN3C(=N2)SC(=N3)S(=O)(=O)N
Standard InChIKey MQUYTXDAVCOCMX-UHFFFAOYSA-N
Standard InChI InChI=1S/C10H8N4O2S2/c11-18(15,16)10-13-14-6-8(12-9(14)17-10)7-4-2-1-3-5-7/h1-6H,(H2,11,15,16)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of AEG 3482

DescriptionInhibitor of c-jun N-terminal kinase (JNK) signaling. Binds Hsp90 and facilitates HSF1 release, induces expression of Hsp70, which in turn blocks JNK activation and JNK-dependent apoptosis. Antiapoptotic; inhibits NGF withdrawal-induced death in SCG neurons (EC50 = 20 μM).

AEG 3482 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

AEG 3482 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of AEG 3482

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.5672 mL 17.8361 mL 35.6722 mL 71.3445 mL 89.1806 mL
5 mM 0.7134 mL 3.5672 mL 7.1344 mL 14.2689 mL 17.8361 mL
10 mM 0.3567 mL 1.7836 mL 3.5672 mL 7.1344 mL 8.9181 mL
50 mM 0.0713 mL 0.3567 mL 0.7134 mL 1.4269 mL 1.7836 mL
100 mM 0.0357 mL 0.1784 mL 0.3567 mL 0.7134 mL 0.8918 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on AEG 3482

AEG3482 is a small-molecule inhibitor of Jun kinase (JNK)-dependent apoptosis. [1,2]

Jun kinases, also called Jun N-terminal kinase stress-activated protein kinases. Activation of the JNK signaling pathway is a major event in neuronal apoptosis. This is proved by pathological specimens from Alzheimer’s disease, as well as samples from mouse models of Alzheimer’s and Huntington’s disease, reveal activated JNK. [2]

AEG3482 blocks apoptosis induced by the p75 neurotrophin receptor (p75NTR) or NRAGE, which is p75NTR’s cytosolic interactor,. AEG3482 inhibits proapoptotic JNK activity. AEG3482 induces production of heat shock protein 70 (HSP70) which is an endogenous inhibitor of JNK. HSP70 accumulation is required for the AEG3482-induced JNK blockade. [1]

As described, activation of C-jun N-terminal kinase (JNK) signaling is associated with neuronal cell death. AEG3482 interacts with heat shock protein 90 leading to inhibition of JNK and blockade of neuronal apoptosis. So AEG3482 can serve as useful tools for basic research, and it may have therapeutic potential for the treatment of acute and chronic neurological disorders. In the neuropathologicalstate, the chaperone-mediated stress response may be primed for response to Hsp90 inhibitors; and AEG3482, may be selective neuroprotective agents.[1,2]

References:
[1]Salehi AH, Morris SJ, Ho WC, etal. , AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70. Chem Biol. 2006 Feb;13(2):213-23.
[2] Gallo KA.   Targeting HSP90 to halt neurodegeneration. Chem Biol. 2006 Feb;13(2):115-6.

Featured Products
New Products
 

References on AEG 3482

Targeting HSP90 to halt neurodegeneration.[Pubmed:16492558]

Chem Biol. 2006 Feb;13(2):115-6.

Activation of c-jun N-terminal kinase (JNK) signaling is associated with neuronal cell death. As described in this issue of Chemistry & Biology, cell-based screening efforts yielded a compound, AEG3482, which interacts with heat shock protein 90 leading to inhibition of JNK and blockade of neuronal apoptosis .

AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70.[Pubmed:16492569]

Chem Biol. 2006 Feb;13(2):213-23.

We describe a group of small-molecule inhibitors of Jun kinase (JNK)-dependent apoptosis. AEG3482, the parental compound, was identified in a screening effort designed to detect compounds that reduce apoptosis of neonatal sympathetic neurons after NGF withdrawal. We show that AEG3482 blocks apoptosis induced by the p75 neurotrophin receptor (p75NTR) or its cytosolic interactor, NRAGE, and demonstrate that AEG3482 blocks proapoptotic JNK activity. We show that AEG3482 induces production of heat shock protein 70 (HSP70), an endogenous inhibitor of JNK, and establish that HSP70 accumulation is required for the AEG3482-induced JNK blockade. We show that AEG3482 binds HSP90 and induces HSF1-dependent HSP70 mRNA expression and find that AEG3482 facilitates HSP70 production while retaining HSP90 chaperone activity. These studies establish that AEG3482 inhibits JNK activation and apoptosis by a mechanism involving induced expression of HSP proteins.

Neuron specific toxicity of oligomeric amyloid-beta: role for JUN-kinase and oxidative stress.[Pubmed:20858948]

J Alzheimers Dis. 2010;22(3):839-48.

Recent studies have demonstrated a potential role for oligomeric forms of amyloid-beta (Abeta) in the pathogenesis of Alzheimer's disease (AD), although it remains unclear which aspects of AD may be mediated by oligomeric Abeta. In the present study, we found that primary cultures of rat cortical neurons exhibit a dose-dependent increase in cell death following Abeta oligomer administration, while primary cultures of astrocytes exhibited no overt toxicity with even the highest concentrations of oligomer treatment. Neither cell type exhibited toxicity when treated by equal concentrations of monomeric Abeta. The neuron death induced by oligomer treatment was associated with an increase in reactive oxygen species (ROS), altered expression of mitochondrial fission and fusion proteins, and JUN kinase activation. Pharmacological inhibition of JUN kinase ameliorated oligomeric Abeta toxicity in neurons. These data indicate that oligomeric Abeta is sufficient to selectively induce toxicity in neurons, but not astrocytes, with neuron death occurring in a JUN kinase-dependent manner. Additionally, these observations implicate a role for oligomeric Abeta as a contributor to neuronal oxidative stress and mitochondrial disturbances in AD.

Keywords:

AEG 3482,63735-71-7,AEG-3482,AEG3482,Natural Products,JNK, buy AEG 3482 , AEG 3482 supplier , purchase AEG 3482 , AEG 3482 cost , AEG 3482 manufacturer , order AEG 3482 , high purity AEG 3482

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: